11
1
1
1
Saturday, June 27, 2009
Wednesday, June 24, 2009
Monday, June 22, 2009
Can Governments Till the Fields of Innovation? - Star-Banner
Can Governments Till the Fields of Innovation? - Star-Banner
INNOVATION — the tricky, many-step process by which ideas become products and services — has typically been seen, studied and celebrated at the micro level, as a pursuit for
Provectus Pharmaceuticals to Offer Compassionate Use of PV-10 for Non - Businesswire.com
KNOXVILLE, Tenn.--( BUSINESS WIRE )--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT ), a development-stage oncology and dermatology biopharmaceutical company, has begun a
MMR Information Systems Pursues International Patent Applications on - Market Wire
Anti-CD20 antibodies are useful in treating B-Cell malignancies, including Non-Hodgkin Lymphoma (NHL) and additional B-Cell mediated conditions such as rheumatoid arthritis. The
Psoriasis drug Raptiva pulled from global market due to safety - Canada East
TORONTO - Health Canada is advising consumers that the company that distributes the psoriasis drug Raptiva is pulling the product from the market due to safety concerns. Raptiva
Can Governments Till the Fields of Innovation? - Star-Banner
INNOVATION — the tricky, many-step process by which ideas become products and services — has typically been seen, studied and celebrated at the micro level, as a pursuit for
Provectus Pharmaceuticals to Offer Compassionate Use of PV-10 for Non - Businesswire.com
KNOXVILLE, Tenn.--( BUSINESS WIRE )--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT ), a development-stage oncology and dermatology biopharmaceutical company, has begun a
MMR Information Systems Pursues International Patent Applications on - Market Wire
Anti-CD20 antibodies are useful in treating B-Cell malignancies, including Non-Hodgkin Lymphoma (NHL) and additional B-Cell mediated conditions such as rheumatoid arthritis. The
Psoriasis drug Raptiva pulled from global market due to safety - Canada East
TORONTO - Health Canada is advising consumers that the company that distributes the psoriasis drug Raptiva is pulling the product from the market due to safety concerns. Raptiva
INNOVATION — the tricky, many-step process by which ideas become products and services — has typically been seen, studied and celebrated at the micro level, as a pursuit for
Provectus Pharmaceuticals to Offer Compassionate Use of PV-10 for Non - Businesswire.com
KNOXVILLE, Tenn.--( BUSINESS WIRE )--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT ), a development-stage oncology and dermatology biopharmaceutical company, has begun a
MMR Information Systems Pursues International Patent Applications on - Market Wire
Anti-CD20 antibodies are useful in treating B-Cell malignancies, including Non-Hodgkin Lymphoma (NHL) and additional B-Cell mediated conditions such as rheumatoid arthritis. The
Psoriasis drug Raptiva pulled from global market due to safety - Canada East
TORONTO - Health Canada is advising consumers that the company that distributes the psoriasis drug Raptiva is pulling the product from the market due to safety concerns. Raptiva
Can Governments Till the Fields of Innovation? - Star-Banner
INNOVATION — the tricky, many-step process by which ideas become products and services — has typically been seen, studied and celebrated at the micro level, as a pursuit for
Provectus Pharmaceuticals to Offer Compassionate Use of PV-10 for Non - Businesswire.com
KNOXVILLE, Tenn.--( BUSINESS WIRE )--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT ), a development-stage oncology and dermatology biopharmaceutical company, has begun a
MMR Information Systems Pursues International Patent Applications on - Market Wire
Anti-CD20 antibodies are useful in treating B-Cell malignancies, including Non-Hodgkin Lymphoma (NHL) and additional B-Cell mediated conditions such as rheumatoid arthritis. The
Psoriasis drug Raptiva pulled from global market due to safety - Canada East
TORONTO - Health Canada is advising consumers that the company that distributes the psoriasis drug Raptiva is pulling the product from the market due to safety concerns. Raptiva
-----------------------------
